Last updated: 2026-10-14 22:05:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Pacific Biosciences of California, Inc. (PACB) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $1.99, with a market capitalization of $652.74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.07 to $3.44. This page covers its latest market performance, valuation, price trends and company information.
$652.74M | |
$2.00 | |
$53.69 | |
$0.85 | |
$2.05 | |
8.76M | |
10.85M | |
-- | |
$3.44 | |
$1.07 | |
-- | |
-- |
Pacific Biosciences of California, Inc. (PACB) is trading at $1.95 in after-hours trading as of 2026-10-14 21:51:00, down 4.68% ($0.10) from the regular-session close of $2.05.
After-hours trading shows how investors are pricing PACB after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Pacific Biosciences of California, Inc. (PACB) moved from $2.87 to $1.99, representing a decline of 30.84% ($0.89).
The stock traded between $1.96 and $3.44 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 22.15 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 38.7%
PACB is currently trading at $1.99, placing it 38.7% of the way from its 52-week low of $1.07 to its 52-week high of $3.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 485 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Pacific Biosciences of California, Inc. (PACB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.